Amsterdam UMC location University of Amsterdam, Experimental Vascular Medicine, 1105AZ Amsterdam, Netherlands.
Amsterdam Cardiovascular Sciences, Diabetes and Metabolism, 1105AZ Amsterdam, Netherlands.
Sci Transl Med. 2023 Nov 22;15(723):eadg2773. doi: 10.1126/scitranslmed.adg2773.
Obesity has become a worldwide pandemic affecting more than 650 million people and is associated with a high burden of morbidity. Alongside traditional risk factors for obesity, the gut microbiome has been identified as a potential factor in weight regulation. Although rodent studies suggest a link between the gut microbiome and body weight, human evidence for causality remains scarce. In this Review, we postulate that existing evidence remains to establish a contribution of the gut microbiome to the development of obesity in humans but that modified probiotic strains and supraphysiological dosages of microbial metabolites may be beneficial in combatting obesity.
肥胖已成为全球性大流行病,影响着超过 6.5 亿人,并与高发病率负担相关。除了肥胖的传统危险因素外,肠道微生物组也被认为是体重调节的一个潜在因素。尽管啮齿动物研究表明肠道微生物组与体重之间存在关联,但人类因果关系的证据仍然很少。在这篇综述中,我们假设现有证据仍有待确定肠道微生物组对人类肥胖发展的贡献,但经过改良的益生菌菌株和微生物代谢物的超生理剂量可能有助于对抗肥胖。